Overview: C1q Complement TestIntroduction: The C1q Complement Test measures C1q complement levels to diagnose immune deficiencies, causing frequent infections or autoimmune issues. Following 2023 AAAAI guidelines, it uses an immunoassay for high sensitivity, aiding in autoimmune screening. This test is critical for guiding diagnosis, treatment, and improving outcomes in immunology for patients with suspected immune deficiencies.
Other Names: C1q Assay, Complement Deficiency Test.
FDA Status: Laboratory-developed test (LDT), meeting immunology standards for diagnostic accuracy.
Historical Milestone: Complement testing began in the 1960s with immune research. C1q-specific assays emerged in the 1980s, and by the 2000s, immunoassays improved deficiency detection.
Purpose: Diagnoses immune deficiencies, guides treatment, and monitors complement levels in patients with frequent infections or autoimmune issues.
Test Parameters: 1. C1q Complement
Pretest Condition: No fasting required. Collect serum or plasma at any time. Report symptoms like infections or autoimmune symptoms, and list medications like immunosuppressants.
Specimen: 2-5 mL serum (SST) or 2-4 mL plasma (EDTA). Centrifuge within 1 hour. Transport in a biohazard bag within 8 hours.
Sample Stability at Room Temperature: 8 hours
Sample Stability at Refrigeration: 7 days
Sample Stability at Frozen: 6 months
Medical History: Document frequent infections, autoimmune conditions, or family history of immune deficiencies. Include current medications, especially immunosuppressants.
Consent: Written consent required, detailing the tests purpose, diagnostic implications, and potential need for immune therapy.
Procedural Considerations: Uses an immunoassay to measure C1q complement levels. Results are available in 3-5 days, supporting clinical decisions.
Factors Affecting Result Accuracy: Immunosuppressants or improper storage can affect results. Hemolysis may degrade samples.
Clinical Significance: Low C1q levels confirm immune deficiency, prompting immunoglobulin therapy. Normal levels suggest alternative diagnoses.
Specialist Consultation: Consult an immunologist for result interpretation. A rheumatologist referral is advised for autoimmune cases.
Additional Supporting Tests: C3/C4 complement tests, immunoglobulin levels, or genetic testing to confirm immune deficiency.
Test Limitations: False negatives may occur with early disease. Results require clinical correlation.
References: AAAAI Complement Guidelines, 2023; Journal of Clinical Immunology, Botto M, 2022.
